|
1
|
Maderna E, Salmaggi A, Calatozzolo C,
Limido L and Pollo B: Nestin, PDGFRbeta, CXCL12 and VEGF in glioma
patients: Different profiles of (pro-angiogenic) molecule
expression are related with tumor grade and may provide prognostic
information. Cancer Biol Ther. 6:1018–1024. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gravdal K, Halvorsen OJ, Haukaas SA and
Akslen LA: Proliferation of immature tumor vessels is a novel
marker of clinical progression in prostate cancer. Cancer Res.
69:4708–4715. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamahatsu K, Matsuda Y, Ishiwata T, Uchida
E and Naito Z: Nestin as a novel therapeutic target for pancreatic
cancer via tumor angiogenesis. Int J Oncol. 40:1345–1357.
2012.PubMed/NCBI
|
|
4
|
Chen Z, Wang J, Cai L, Zhong B, Luo H, Hao
Y, Yu W, Wang B, Su C, Lei Y, Bella AE, Xiang AP and Wang T: Role
of the stem cell-associated intermediate filament nestin in
malignant proliferation of non-small cell lung cancer. PLoS One.
9:e855842014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Teranishi N, Naito Z, Ishiwata T, Tanaka
N, Furukawa K, Seya T, Shinji S and Tajiri T: Identification of
neovasculature using nestin in colorectal cancer. Int J Oncol.
30:593–603. 2007.PubMed/NCBI
|
|
6
|
Piras F, Ionta MT, Lai S, Perra MT, Atzori
F, Minerba L, Pusceddu V, Maxia C, Murtas D, Demurtas P, Massidda B
and Sirigu P: Nestin expression associates with poor prognosis and
triple negative phenotype in locally advanced (T4) breast cancer.
Eur J Histochem. 55:e392011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Strojnik T, Røsland GV, Sakariassen PO,
Kavalar R and Lah T: Neural stem cell markers, nestin and musashi
proteins, in the progression of human glioma: Correlation of nestin
with prognosis of patient survival. Surg Neurol. 68:133–144. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ishiwata T, Teduka K, Yamamoto T, Kawahara
K, Matsuda Y and Naito Z: Neuroepithelial stem cell marker nestin
regulates the migration, invasion and growth of human gliomas.
Oncol Rep. 26:91–99. 2011.PubMed/NCBI
|
|
9
|
Liu J and Brown RE: Immunohistochemical
detection of epithelialmesenchymal transition associated with
stemness phenotype in anaplastic thyroid carcinoma. Int J Clin Exp
Pathol. 3:755–762. 2010.PubMed/NCBI
|
|
10
|
Sherman SI: Thyroid carcinoma. Lancet.
361:501–511. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tennvall J, Lundell G, Wahlberg P,
Bergenfelz A, Grimelius L, Akerman M, Hjelm Skog AL and Wallin G:
Anaplastic thyroid carcinoma: three protocols combining
doxorubicin, hyperfractionated radiotherapy and surgery. Br J
Cancer. 86:1848–1853. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sugitani I, Kasai N, Fujimoto Y and
Yanagisawa A: Prognostic factors and therapeutic strategy for
anaplastic carcinoma of the thyroid. World J Surg. 25:617–622.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsutsui K: Chemotherapy of the anaplastic
thyroid cancer. Naibunpitsu Geka. 12:133–139. 1995.(In
Japanese).
|
|
14
|
Kasiwagi S, Yashiro M, Takashima T,
Aomatsu N, Kawajiri H, Ogawa Y, Onoda N, Ishikawa T, Wakasa K and
Hirakawa K: c-Kit expression as a prognostic molecular marker in
patients with basal-like breast cancer. Br J Surg. 100:490–496.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smallridge RC and Copland JA: Anaplastic
thyroid carcinoma: Pathogenesis and emerging therapies. Clin Oncol.
22:486–497. 2010. View Article : Google Scholar
|
|
16
|
Kebebew E, Greenspan FS, Clark OH, Woeber
KA and McMillan A: Anaplastic thyroid carcinoma. Treatment outcome
and prognostic factors. Cancer. 103:1330–1335. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yau T, Lo CY, Epstein RJ, Lam AK, Wan KY
and Lang BH: Treatment outcomes in anaplastic thyroid carcinoma:
Survival improvement in young patients with localized disease
treated by combination of surgery and radiotherapy. Ann Surg Oncol.
15:2500–2505. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Akaishi J, Sugino K, Kitagawa W, Nagahama
M, Kameyama K, Shimizu K and Ito K: Prognostic factors and
treatment outcomes of 100 cases of anaplastic thyroid carcinoma.
Thyroid. 21:1183–1189. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Orita Y, Sugitani I, Amemiya T and
Fujimoto Y: Prospective application of our novel prognostic index
in the treatment of anaplastic thyroid carcinoma. Surgery.
150:1212–1219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sugitani I, Miyauchi A, Sugino K, Okamoto
T, Yoshida A and Suzuki S: Prognostic factors and treatment
outcomes for anaplastic thyroid carcinoma: ATC Research Consortium
of Japan cohort study of 677 patients. World J Surg. 36:1247–1254.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brychtova S, Fiuraskova M, Hlobilková A,
Brychta T and Hirnak J: Nestin expression in cutaneous melanomas
and melanocytic nevi. J Cutan Pathol. 34:370–375. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kleeberger W, Bova GS, Nielsen ME, Herawi
M, Chuang AY, Epstein JI and Berman DM: Roles for the stem cell
associated intermediate filament Nestin in prostate cancer
migration and metastasis. Cancer Res. 67:9199–9206. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matsuda Y, Hagio M and Ishiwata T: Nestin:
A novel angiogenesis marker and possible target for tumor
angiogenesis. World J Gastroenterol. 19:42–48. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Narita K, Matsuda Y, Seike M, Naito Z,
Gemma A and Ishiwata T: Nestin regulates proliferation, migration,
invasion and stemness of lung adenocarcinoma. Int J Oncol.
44:1118–1130. 2014.PubMed/NCBI
|
|
25
|
Matsuda Y, Naito Z, Kawahara K, Nakazawa
N, Korc M and Ishiwata T: Nestin is a novel target for suppressing
pancreatic cancer cell migration, invasion and metastasis. Cancer
Biol Ther. 11:512–523. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suman S, Rodriguez OC, Winters TA, Fornace
AJ Jr, Albanese C and Datta K: Therapeutic and space radiation
exposure of mouse brain causes impaired DNA repair response and
premature senescence by chronic oxidant production. Aging (Albany
NY). 5:607–622. 2013.PubMed/NCBI
|
|
27
|
Onoda N, Nakamura M, Aomatsu N, Noda S,
Kashiwagi S and Hirakawa K: Establishment, characterization and
comparison of seven authentic anaplastic thyroid cancer cell lines
retaining clinical features of the original tumors. World J Surg.
38:688–695. 2014. View Article : Google Scholar : PubMed/NCBI
|
